EK
EKF Diagnostics Holdings plc
EKDHF · OTC
$0.34 +0.00% (+$0.00)
Market Cap £108.3M
P/E Ratio 51.04x
Div. Yield -
ROE 3.01%
Bulios Fair Price
$0.23
32.4% downside
Current Price
$0.34
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EKDHF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
60 /100
Fair EV/EBITDA 13.91x
P/S 2.10x
P/B 1.57x
Growth
38 /100
Stable FCF growth 28.42%
Book val. growth 2.00%
Rev. growth 8.20%
Profitability
70 /100
Strong Net margin 4.12%
Op. margin 13.08%
FCF margin 15.86%
Quality
21 /100
Poor ROE 3.01%
ROA 2.62%
Asset turnover 0.64x
Debt
100 /100
Low Current ratio 4.16x
Int. coverage 43.81x
Net debt/EBITDA -2.14x
Stability
52 /100
Moderate Rev. volatility 12.17%
EPS volatility 123.54%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EKDHF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Gavin Joseph Jones
Employees
301
Headquarters
Cardiff
Upcoming events
15 SEP
Earnings
Upcoming earnings report